- Home
- QDEL vs ACHC Comparison
QDEL vs ACHC Comparison
Compare QDEL & ACHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QDEL | ACHC |
|---|---|---|
| Founded | 1979 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.1B |
| IPO Year | 2022 | 2011 |
Fundamental Metrics
Financial Performance| Metric | QDEL | ACHC |
|---|---|---|
| Price | $11.93 | $23.14 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 15 |
| Target Price | ★ $28.25 | $22.67 |
| AVG Volume (30 Days) | 2.2M | ★ 2.9M |
| Earning Date | 05-05-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 45.35 | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | $2,730,200,000.00 | ★ $3,312,769,000.00 |
| Revenue This Year | $3.51 | $5.08 |
| Revenue Next Year | $3.86 | $5.98 |
| P/E Ratio | ★ N/A | $456.60 |
| Revenue Growth | N/A | ★ 5.04 |
| 52 Week Low | $9.92 | $11.43 |
| 52 Week High | $35.58 | $30.20 |
Technical Indicators
Market Signals| Indicator | QDEL | ACHC |
|---|---|---|
| Relative Strength Index (RSI) | 47.70 | 37.66 |
| Support Level | $10.39 | $21.66 |
| Resistance Level | $12.85 | $24.90 |
| Average True Range (ATR) | 0.95 | 1.25 |
| MACD | 0.34 | -0.44 |
| Stochastic Oscillator | 70.14 | 12.71 |
Price Performance
Historical ComparisonAbout QDEL QuidelOrtho Corporation
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.
About ACHC Acadia Healthcare Company Inc.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.